logo

Targeted medical pharma develops new medical food for autism spectrum disorders

LOS ANGELES--(BUSINESS WIRE)--. (OTCQB: TRGM) today announced that the company will begin a clinical trial on a new medical food indicated for the dietary management of Autism and Autism Spectrum Disorders.
Read Full Item
http://eon.businesswire.com/news/eon/20130830005566/en
Date
30th August 2013
Source
Enhanced Online News